LFCR
Price
$6.87
Change
+$0.13 (+1.93%)
Updated
Oct 8 closing price
Capitalization
257.39M
84 days until earnings call
LNTH
Price
$53.55
Change
+$1.71 (+3.30%)
Updated
Oct 8 closing price
Capitalization
3.64B
21 days until earnings call
Interact to see
Advertisement

LFCR vs LNTH

Header iconLFCR vs LNTH Comparison
Open Charts LFCR vs LNTHBanner chart's image
Lifecore Biomedical
Price$6.87
Change+$0.13 (+1.93%)
Volume$125.13K
Capitalization257.39M
Lantheus Holdings
Price$53.55
Change+$1.71 (+3.30%)
Volume$2.79M
Capitalization3.64B
LFCR vs LNTH Comparison Chart in %
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. LNTH commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and LNTH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (LFCR: $6.87 vs. LNTH: $53.55)
Brand notoriety: LFCR and LNTH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 77% vs. LNTH: 146%
Market capitalization -- LFCR: $257.39M vs. LNTH: $3.64B
LFCR [@Pharmaceuticals: Generic] is valued at $257.39M. LNTH’s [@Pharmaceuticals: Generic] market capitalization is $3.64B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileLNTH’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • LNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, LNTH is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while LNTH’s TA Score has 2 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 6 bearish.
  • LNTH’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, LNTH is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -4.18% price change this week, while LNTH (@Pharmaceuticals: Generic) price change was +3.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.16%. For the same industry, the average monthly price growth was +5.42%, and the average quarterly price growth was +62.58%.

Reported Earning Dates

LFCR is expected to report earnings on Jan 01, 2026.

LNTH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($3.64B) has a higher market cap than LFCR($257M). LFCR has higher P/E ratio than LNTH: LFCR (51.23) vs LNTH (14.24). LFCR YTD gains are higher at: -7.537 vs. LNTH (-40.141). LNTH has higher annual earnings (EBITDA): 457M vs. LFCR (-8.81M). LNTH has more cash in the bank: 696M vs. LFCR (8.27M). LFCR has less debt than LNTH: LFCR (131M) vs LNTH (615M). LNTH has higher revenues than LFCR: LNTH (1.52B) vs LFCR (129M).
LFCRLNTHLFCR / LNTH
Capitalization257M3.64B7%
EBITDA-8.81M457M-2%
Gain YTD-7.537-40.14119%
P/E Ratio51.2314.24360%
Revenue129M1.52B8%
Total Cash8.27M696M1%
Total Debt131M615M21%
FUNDAMENTALS RATINGS
LFCR vs LNTH: Fundamental Ratings
LFCR
LNTH
OUTLOOK RATING
1..100
7016
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
10038
PRICE GROWTH RATING
1..100
6093
P/E GROWTH RATING
1..100
676
SEASONALITY SCORE
1..100
n/a17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (58) in the Medical Specialties industry is somewhat better than the same rating for LFCR (99) in the Industrial Specialties industry. This means that LNTH’s stock grew somewhat faster than LFCR’s over the last 12 months.

LNTH's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that LNTH’s stock grew somewhat faster than LFCR’s over the last 12 months.

LNTH's SMR Rating (38) in the Medical Specialties industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that LNTH’s stock grew somewhat faster than LFCR’s over the last 12 months.

LFCR's Price Growth Rating (60) in the Industrial Specialties industry is somewhat better than the same rating for LNTH (93) in the Medical Specialties industry. This means that LFCR’s stock grew somewhat faster than LNTH’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for LNTH (76) in the Medical Specialties industry. This means that LFCR’s stock grew significantly faster than LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRLNTH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLCFF0.030.01
+25.63%
Christina Lake Cannabis Corp.
FRFHF1767.9415.67
+0.89%
Fairfax Financial Holdings Ltd.
PMREF11.14N/A
N/A
PRIMARIS REAL ESTATE INV TRUST TR.
OFED15.30N/A
N/A
Oconee Federal Financial Corp.
FOSUY15.14N/A
N/A
Fosun International, Ltd.

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.93%
NBIX - LFCR
36%
Loosely correlated
+1.52%
SHPH - LFCR
31%
Poorly correlated
+4.52%
ALKS - LFCR
30%
Poorly correlated
+1.81%
AMRX - LFCR
30%
Poorly correlated
+1.16%
PBH - LFCR
28%
Poorly correlated
+0.67%
More

LNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, LNTH has been loosely correlated with EOLS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LNTH jumps, then EOLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+3.30%
EOLS - LNTH
33%
Loosely correlated
-0.80%
ACET - LNTH
32%
Poorly correlated
+8.86%
CRDL - LNTH
27%
Poorly correlated
+1.89%
SNDL - LNTH
26%
Poorly correlated
-0.75%
LFCR - LNTH
24%
Poorly correlated
+1.93%
More